A ROS-Tyrosinase Cascade-Activated Prodrug for Selectively Suppressing Melanoma

“Off-target effect” is one of the obstacles for targeted prodrugs in chemotherapy. To circumvent this issue, herein we proposed a dual biomarker cascade-activated prodrug strategy based on high lev...